# DAY ONE BIOPHARMACEUTICALS I (DAWN)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DAWN/

- Reporting holders: 1
- Reported value: $3.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $3.6K | 165 | 0.0% | 12 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 1 | $3.6K |
| Q1 2026 | 213 | $1.9B |
| Q4 2025 | 186 | $777.9M |
| Q3 2025 | 174 | $616.2M |
| Q2 2025 | 175 | $569.6M |
| Q1 2025 | 183 | $753.1M |
| Q4 2024 | 166 | $1.2B |
| Q3 2024 | 167 | $1.3B |
| Q2 2024 | 156 | $1.0B |
| Q1 2024 | 147 | $1.2B |
| Q4 2023 | 140 | $1.1B |
| Q3 2023 | 129 | $953.5M |